Coronavirus Update: Gilead Publishes Promising Results on Remdesivir

2020-10-09 1 Dailymotion

Here's the latest on the coronavirus pandemic.

Related Videos

Gilead Publishes Year in Review 2016 (2) | Gilead

Gilead Publishes Year in Review 2016 (3) | Gilead

Gilead Publishes Year in Review 2016 | Gilead

TheStreet Stocks & Markets Podcast #8: Common Sense Investing With David Miller

Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course

Gilead Donates Entire Remdesivir Supply

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment

Gilead to expand availability of Remdesivir in India

Remdesivir to arrive at hospitals this week, Gilead CEO says